Autopsy report · NCT04054115

Acute Effects of the Prostaglandin (Alprostadil) on Cerebral and Pulmonary Flow

“Covid 19 and difficulty with recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 3 years 4 months before it stopped.
• 10 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

The Hospital for Sick Children

Sponsor type

University, hospital or other

Conditions

Congenital Heart Disease

Interventions

Alprostadil 5 MCG Injection

Participants

10

Sites

1

Countries

Canada

Trials that died the same way

• Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery
  “COVID-19 challenges to recruitment” (95% match in meaning)
• Serum Concentrations of Pregnancy-associated Proteins for Assessment of Gestational Age Before Abortion
  “COVID 19 related recruitment problems” (94% match in meaning)
• Compression Wraps as Adjuvant Therapy in Management of Acute Systolic Heart Failure
  “challenges in recruitment due to covid-19” (93% match in meaning)
• Pathology and Imaging in Kidney Allografts
  “recruitment difficulties due to impact of COVID-19 pandemic” (92% match in meaning)
• Effects of Music Based Intervention (MBI) on Pain Response and Neurodevelopment in Preterm Infants
  “Due to Covid constraints on recruitment” (89% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.